Skip Navigation

Rheumatology 2004 43(8):1057-1058; doi:10.1093/rheumatology/keh218
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mavrikakis, I.
Right arrow Articles by Mavrikakis, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mavrikakis, I.
Right arrow Articles by Mavrikakis, E.
Related Collections
Right arrow Education
Right arrow Rheumatoid Arthritis
Right arrow Systemic Lupus Erythematosus and Autoimmunity
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology Vol. 43 No. 8 © British Society for Rheumatology 2004; all rights reserved

Letter to the Editor

Are evidence-based guidelines being followed for the monitoring of ocular toxicity of hydroxychloroquine? A nationwide survey of practice amongst consultant rheumatologists and implications for clinical governance. Comment on the article by Samanta et al.

I. Mavrikakis and E. Mavrikakis

Sussex Eye Hospital, Brighton and Sussex University Hospitals, Brighton, UK

Correspondence to: I. Mavrikakis, Sussex Eye Hospital, Eastern Road, Brighton BN2 5BF, UK. E-mail: jmavrikakis@yahoo.com

The first 10% of the full text of this article appears below.

SIR, We read with interest the article by Samanta et al. on the question of whether evidence-based guidelines are being followed for the monitoring of ocular toxicity of hydroxychloroquine [1]. As the authors demonstrate, the nationally set guidelines for the monitoring of ocular toxicity of hydroxychloroquine [. . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?